Procter & Gamble's Mixed Bag Q1: EPS Exceeds Estimates, Reaffirms Growth Outlook & More
Portfolio Pulse from Lekha Gupta
Procter & Gamble (PG) reported mixed Q1 results with EPS beating estimates but sales slightly missing expectations. Organic sales grew by 2%, driven by higher pricing and volume. The company reaffirmed its FY25 guidance and continues to focus on its growth strategy. PG shares are trading lower, down 0.81% premarket.
October 18, 2024 | 12:24 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Fidelity MSCI Consumer Staples Index ETF (FSTA) includes Procter & Gamble, which reported mixed Q1 results. PG's performance may affect FSTA's short-term price.
Given PG's weight in FSTA, the mixed earnings report and the decline in PG's stock price could have a negative short-term impact on FSTA.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50
NEGATIVE IMPACT
iShares U.S. Consumer Staples ETF (IYK) includes Procter & Gamble, which reported mixed Q1 results. PG's performance may impact IYK's short-term movement.
As PG is a significant component of IYK, its mixed earnings report and the subsequent drop in PG's stock price could negatively impact IYK in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50
NEGATIVE IMPACT
Procter & Gamble's Q1 results show EPS exceeding estimates but sales missing slightly. Organic sales grew by 2%, and the company reaffirmed its FY25 guidance. Despite positive EPS, shares are trading lower.
Despite beating EPS estimates, the slight miss in sales and the decline in key segments like Beauty and Baby, Feminine & Family Care have likely contributed to the negative market reaction. The reaffirmation of guidance provides some stability, but the immediate market response is negative.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100